Myomo, Inc. (MYO)
Myomo, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Burlington, MA, US. The stock last traded at $1.50, down 0.33% on the session, giving a market capitalisation of $58.2M. On trailing twelve-month figures it carries a trailing P/E of -4.42, a net margin of -33.5%. Its beta of 1.44 implies it has historically moved more than the broad market.
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Myomo, Inc. is most often compared with the following Healthcare names: